Literature DB >> 25527564

Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder.

Paneez Khoury1, Jacqueline Herold2, Alexandra Alpaugh2, Ellen Dinerman2, Nicole Holland-Thomas3, Jennifer Stoddard4, Shakuntala Gurprasad4, Irina Maric4, Olga Simakova4, Lawrence B Schwartz5, Juelia Fong2, Chyi-Chia Richard Lee6, Liqiang Xi6, Zengfeng Wang6, Mark Raffeld6, Amy D Klion2.   

Abstract

Episodic angioedema with eosinophilia (Gleich syndrome) is a rare disorder characterized by episodes of angioedema and eosinophilia that occur at monthly intervals and resolve spontaneously without therapy. Despite the striking periodicity of this disorder, its similarity to other cyclic hematopoietic disorders with multilineage involvement has not been assessed. To characterize the involvement of cell lineages in the etiology and pathogenesis of episodic angioedema with eosinophilia, four subjects were evaluated by blood counts and other analyses over the course of 1-2 months. Surface marker expression was assessed on T cells by flow cytometry and clonality by polymerase chain reaction. Intracellular cytokine evaluation, bone marrow and skin biopsies were performed during different parts of the cycle. Cycling of multiple cell lineages, including neutrophils, lymphocytes and eosinophils, was observed in the four subjects with the disorder with a periodicity of 25-35 days. An aberrant CD3(-)CD4(+) T-cell population was detected in all four subjects, and T-cell receptor rearrangement studies showed a clonal pattern in three subjects. A peak of type II cytokines was detected in the serum of subjects prior to the onset of symptoms and eosinophil cycling and corresponded to ex-vivo type II cytokines detected intracellularly in CD3(+)CD4(+)CD154(+) T cells. Although the etiology of episodic angioedema with eosinophilia is not yet known, multiple lineages, including lymphocytes, neutrophils and mast cells, are involved and may be related to disease pathogenesis. Whether these cells act directly or promote eosinophilia and eosinophil activation remains to be elucidated. All subjects gave informed consent and were evaluated under an Institutional Review Board-approved protocol (NCT00001406). Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25527564      PMCID: PMC4349267          DOI: 10.3324/haematol.2013.091264

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  28 in total

1.  Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells.

Authors:  Lawrence B Schwartz; Hae-Ki Min; Shunlin Ren; Han-Zhang Xia; Jiang Hu; Wei Zhao; George Moxley; Yoshihiro Fukuoka
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

2.  Clonal T cell-mediated cyclic thrombocytopenia.

Authors:  Wolfgang Füreder; Gerlinde Mitterbauer; Renate Thalhammer; Klaus Geissler; Simon Panzer; Michael Krebs; Ingrig Simonitsch-Klupp; Wolfgang R Sperr; Klaus Lechner; Paul A Kyrle
Journal:  Br J Haematol       Date:  2002-12       Impact factor: 6.998

3.  Cycling of peripheral blood and marrow lymphocytes in cyclic neutropenia.

Authors:  D Engelhard; K S Landreth; N Kapoor; P W Kincade; L E De Bault; A Theodore; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

4.  Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.

Authors:  D C Dale; R E Person; A A Bolyard; A G Aprikyan; C Bos; M A Bonilla; L A Boxer; G Kannourakis; C Zeidler; K Welte; K F Benson; M Horwitz
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

Review 5.  Clonal T-helper lymphocytes and elevated IL-5 levels in episodic angioedema and eosinophilia (Gleich's syndrome).

Authors:  Susan J Morgan; H Miles Prince; David A Westerman; Christopher McCormack; Ian Glaspole
Journal:  Leuk Lymphoma       Date:  2003-09

6.  Episodic angioedema associated with eosinophilia.

Authors:  G J Gleich; A L Schroeter; J P Marcoux; M I Sachs; E J O'Connell; P F Kohler
Journal:  N Engl J Med       Date:  1984-06-21       Impact factor: 91.245

Review 7.  ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.

Authors:  Marshall S Horwitz; Seth J Corey; H Leighton Grimes; Timothy Tidwell
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-07       Impact factor: 3.722

Review 8.  The hypereosinophilic syndrome revisited.

Authors:  Florence Roufosse; Elie Cogan; Michel Goldman
Journal:  Annu Rev Med       Date:  2001-12-03       Impact factor: 13.739

9.  Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins.

Authors:  L M Zheutlin; S J Ackerman; G J Gleich; L L Thomas
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

10.  Activation of basophil and mast cell histamine release by eosinophil granule major basic protein.

Authors:  M C O'Donnell; S J Ackerman; G J Gleich; L L Thomas
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more
  20 in total

1.  Hypereosinophilia in Children and Adults: A Retrospective Comparison.

Authors:  Kelli W Williams; JeanAnne Ware; Annalise Abiodun; Nicole C Holland-Thomas; Paneez Khoury; Amy D Klion
Journal:  J Allergy Clin Immunol Pract       Date:  2016-04-27

Review 2.  How I treat hypereosinophilic syndromes.

Authors:  Amy D Klion
Journal:  Blood       Date:  2015-05-11       Impact factor: 22.113

3.  Eosinophils and eosinophil-associated diseases: An update.

Authors:  Jeremy A O'Sullivan; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2017-10-16       Impact factor: 10.793

Review 4.  Eosinophilia.

Authors:  Anna Kovalszki; Peter F Weller
Journal:  Prim Care       Date:  2016-10-14       Impact factor: 2.907

5.  Unravelling the NERDS syndrome.

Authors:  Achintya Dinesh Singh; Tejas Menon Suri; Rakesh Kumar Jagdish; Uma Kumar
Journal:  BMJ Case Rep       Date:  2018-05-12

6.  Development of eosinophilic endomyocardial disease in a patient with episodic angioedema and eosinophilia.

Authors:  Benjamin L Wright; Joseph H Butterfield; Kristin M Leiferman; Gerald J Gleich
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

Review 7.  Contributions of Eosinophils to Human Health and Disease.

Authors:  Amy D Klion; Steven J Ackerman; Bruce S Bochner
Journal:  Annu Rev Pathol       Date:  2020-01-24       Impact factor: 23.472

Review 8.  What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?

Authors:  Julien Catherine; Florence Roufosse
Journal:  Semin Immunopathol       Date:  2021-05-19       Impact factor: 9.623

Review 9.  Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.

Authors:  Peter Valent; Lina Degenfeld-Schonburg; Irina Sadovnik; Hans-Peter Horny; Michel Arock; Hans-Uwe Simon; Andreas Reiter; Bruce S Bochner
Journal:  Semin Immunopathol       Date:  2021-05-30       Impact factor: 9.623

Review 10.  Eosinophils in skin diseases.

Authors:  Susanne Radonjic-Hoesli; Marie-Charlotte Brüggen; Laurence Feldmeyer; Hans-Uwe Simon; Dagmar Simon
Journal:  Semin Immunopathol       Date:  2021-06-07       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.